About deCODEHeadquartered in Reykjavik, Iceland, deCODE is using its unique population resources to identify the genetic causes of more than 50 common diseases. deCODE is applying its discoveries to develop new drugs and DNA-based diagnostics that target the underlying biology of disease, not just the signs and symptoms.

    The company is also leveraging its expertise in human genetics to offer innovative products and services in bioinformatics, genotyping, pharmacogenomics and clinical trials. deCODE's US-based pharmaceuticals and structural biology groups conduct downstream development work on targets derived from the company's proprietary research as well as contract service work for pharmaceutical and biotechnology companies.